- Home
- Supplements
- Boswellia
- Pain Relief
Boswellia for Pain Relief
Boswellia shows promising osteoarthritis pain reduction in short trials, often paired with curcumin.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 100-250mg/day standardised to AKBA, or 300-400mg extract three times daily
- Expected timeframe
- 4-8 weeks
Protocol
- form
- Standardised extract with declared AKBA content
- timing
- With a fat-containing meal
- duration
- 4-8 weeks to judge
- titration
- Start at the lower end for two weeks, then increase if needed
- scope note
- The evidence is specifically osteoarthritis pain - boswellia has not been shown to help neuropathic, headache, back or general pain
- measurement
- A daily 0-10 pain score, averaged weekly
- starting dose
- 100-250 mg/day of a high-AKBA standardised extract, or 300-400 mg three times daily of a conventional extract
Evidence
What the studies say
No studies are yet linked to both Boswellia and Pain Relief.
Safety
Caveats
Mild GI upset. Extract standardisation varies widely; unstandardised resin products are unreliable.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.